Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$9.99 - $18.71 $1.28 Million - $2.41 Million
128,622 Added 45.84%
409,183 $7.58 Million
Q2 2023

Aug 07, 2023

SELL
$9.17 - $19.29 $1.18 Million - $2.49 Million
-129,032 Reduced 31.5%
280,561 $3.1 Million
Q1 2023

May 11, 2023

BUY
$12.53 - $21.71 $222,282 - $385,135
17,740 Added 4.53%
409,593 $5.5 Million
Q4 2022

Feb 14, 2023

BUY
$11.61 - $16.11 $3.38 Million - $4.69 Million
291,417 Added 290.15%
391,853 $4.84 Million
Q3 2022

Nov 14, 2022

BUY
$12.21 - $19.7 $1.12 Million - $1.81 Million
91,733 Added 1054.04%
100,436 $1.4 Million
Q2 2022

Aug 09, 2022

SELL
$11.23 - $19.59 $1.14 Million - $1.98 Million
-101,110 Reduced 92.07%
8,703 $120,000
Q1 2022

May 12, 2022

SELL
$13.37 - $17.79 $219,522 - $292,094
-16,419 Reduced 13.01%
109,813 $1.79 Million
Q4 2021

Feb 10, 2022

BUY
$14.28 - $19.53 $1.8 Million - $2.47 Million
126,232 New
126,232 $2.06 Million
Q3 2021

Nov 12, 2021

SELL
$12.99 - $20.47 $781,166 - $1.23 Million
-60,136 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$15.46 - $24.5 $929,702 - $1.47 Million
60,136 New
60,136 $1.2 Million
Q1 2021

May 11, 2021

SELL
$19.33 - $37.75 $48,015 - $93,771
-2,484 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$24.48 - $42.47 $60,808 - $105,495
2,484 New
2,484 $61,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.